Nearly 10,000 participants are in Istanbul at the congress of the ERA-EDTA (European Renal Association – European Dialysis and Transplant Association) to share their knowledge and discuss the latest research findings. New pioneering studies have been presented:
- Gupta, A et al. “SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE”
By SFP-iron administration, the ESA dose could be reduced by 35% while maintaining stable Hb levels. There were no SFP-related adverse effects and no cases of iron overload.
- Van Eps, C. “THE EFFECTS OF TOPICAL ANTIBACTERIAL HONEY ON CATHETER-RELATED INFECTIONS IN PERITONEAL DIALYSISPATIENTS “
The honey-containing wound gel was not superior to mupirocin application for the prophylaxis of PD catheter-associated infections.